CytomX Therapeutics Inc.

CTMX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.79

+$0.03 (+1.09%)

Sep 22, 2026, 10:51 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	1.42M	10.26M	663K	5.96M	18.66M	50.92M	38.09M	33.43M	25.12M	41.46M	26.61M	26.38M	24.72M	23.5M	20.12M	11.15M	12.85M	9.04M	19.73M	17.59M	16.29M	15.97M
Cost of Revenue	n/a	251K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.43M	1.53M	1.5M	n/a	1.49M	n/a	n/a	1.48M	n/a	n/a	n/a
Gross Profit	1.42M	10.01M	663K	5.96M	18.66M	50.92M	38.09M	33.43M	25.12M	41.46M	26.61M	24.96M	23.19M	22M	20.12M	9.66M	12.85M	9.04M	18.24M	17.59M	16.29M	15.97M
Operating Income	-23.78M	-19.67M	-27.93M	-15.77M	-1.29M	22.62M	17.68M	4.11M	-8.45M	11.66M	-606K	11.09M	-3.35M	-5.65M	-9.51M	-29.71M	-30.05M	-32.06M	-26.31M	-22.64M	-19.21M	-15.63M
Interest Income	3.16M	1.49M	1.48M	1.59M	1.18M	955K	1.28M	1.69M	1.97M	2.19M	2.5M	2.7M	2.31M	2.33M	732K	616K	262K	68K	73K	70K	44K	68K
Pretax Income	-20.61M	-18.19M	-26.46M	-14.17M	-91K	23.59M	18.94M	5.8M	-6.48M	13.84M	1.91M	5.82M	-1.09M	-3.31M	-8.78M	-29.06M	-29.5M	-31.98M	-26.23M	-22.58M	-19.24M	-15.55M
Net Income	-20.67M	-18.25M	-26.51M	-14.23M	-154K	23.53M	18.88M	5.74M	-6.53M	13.79M	837K	2.99M	-1.09M	-3.31M	-8.78M	-29.06M	-29.5M	-31.98M	-26.23M	-22.58M	-19.24M	-15.55M
Selling & General & Admin	7.6M	10.69M	7.36M	6.43M	6.62M	9.43M	5.62M	7.95M	8.4M	7.75M	7.83M	3.44M	6.44M	7.04M	7.67M	9.59M	11.75M	10.54M	8.61M	11.09M	9.39M	9.23M
Research & Development	17.6M	19.24M	21.24M	15.3M	13.32M	18.87M	14.79M	21.37M	25.17M	22.05M	19.39M	10.43M	20.1M	20.62M	19.56M	29.78M	31.16M	30.56M	35.94M	29.14M	26.1M	22.37M
Other Expenses	n/a	-251K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.4M	n/a	n/a	-1	n/a	n/a	n/a	n/a
Operating Expenses	25.2M	29.68M	28.6M	21.73M	19.94M	28.3M	20.41M	29.32M	33.57M	29.81M	27.21M	13.87M	26.54M	27.66M	29.63M	39.37M	42.91M	41.1M	44.55M	40.23M	35.49M	31.6M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	25.2M	29.93M	28.6M	21.73M	19.94M	28.3M	20.41M	29.32M	33.57M	29.81M	27.21M	15.29M	28.07M	29.15M	29.63M	40.86M	42.91M	41.1M	46.04M	40.23M	35.49M	31.6M
Income Tax Expense	60K	59K	54K	58K	63K	62K	62K	61K	51K	49K	1.07M	2.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	218.94M	177.27M	170.19M	165M	129.08M	87.12M	80.1M	85.09M	84.88M	82.03M	67.31M	80.73M	66.54M	66.25M	66.23M	65.91M	65.54M	65.39M	65.21M	64.53M	65.06M	60.97M
Shares Outstanding (Diluted)	218.94M	177.27M	170.19M	165M	129.08M	87.15M	80.1M	85.2M	84.88M	82.63M	67.31M	80.99M	66.54M	66.25M	66.23M	65.91M	65.54M	65.39M	65.21M	65.21M	65.06M	60.97M
EPS (Basic)	-0.09	-0.10	-0.17	-0.09	0	0.27	0.24	0.07	-0.08	0.17	0.01	0.04	-0.02	-0.01	-0.40	-0.34	-0.36	-0.36	-0.40	-0.35	-0.30	-0.26
EPS (Diluted)	-0.09	-0.10	-0.17	-0.09	0	0.27	0.24	0.07	-0.08	0.17	0.01	0.04	-0.02	-0.01	-0.40	-0.34	-0.36	-0.36	-0.40	-0.35	-0.30	-0.26
EBITDA	-20.31M	-17.94M	-25.95M	-14.04M	256K	23.97M	19.35M	6.23M	-6.02M	14.31M	2.39M	7.24M	445K	-1.82M	-1.4M	-27.58M	-28.89M	-31.38M	-24.75M	-21.9M	-18.57M	-14.95M
EBIT	-20.61M	-18.19M	-26.46M	-14.17M	-91K	23.59M	18.94M	5.8M	-6.48M	13.84M	1.91M	5.82M	-1.09M	-3.31M	-2.01M	-29.06M	-29.5M	-31.98M	-26.23M	-22.58M	-19.24M	-15.63M
Depreciation & Amortization	298K	251K	510K	134K	347K	385K	413K	429K	459K	467K	486K	1.43M	1.53M	1.5M	608K	1.49M	610K	602K	1.48M	680K	677K	674K